An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Ipamorelin: Benefits, Dosage & Risks (2025) Huddle Men's Health FDA's Overreach on Compounded Peptides Ipamorelin & CJC 1295 Banned Now What? Advanced TRT Clinic